Naloxone Administration for Tramadol Overdose with Respiratory Depression

Introduction to Naloxone Administration

The American Heart Association recommends that naloxone should be administered when tramadol overdose causes respiratory arrest, but standard airway management with bag-mask ventilation takes absolute priority and must not be delayed 1
The American Heart Association suggests immediately beginning bag-mask ventilation to support breathing while preparing naloxone, and administering naloxone if the patient has a definite pulse but no normal breathing or only gasping 1, 2

The American Academy of Pediatrics recommends an initial dose of 0.01 mg/kg IV for children, and if inadequate response, 0.1 mg/kg may be administered, with alternative pediatric dosing of <5 years or <20 kg: 0.1 mg/kg; ≥5 years or ≥20 kg: 2 mg 3, 4
The guideline society suggests a continuous naloxone infusion is indicated when respiratory depression recurs after initial bolus doses, particularly with tramadol's prolonged effects, with the infusion rate titrated to maintain adequate respiratory function without complete reversal 2

The American Heart Association recommends observing patients continuously for at least 2 hours after the last naloxone dose for recurrence of respiratory depression, and monitoring for opioid withdrawal symptoms, with extended observation may be required as tramadol effects can persist beyond naloxone's duration 1, 2, 4
The American Academy of Pediatrics advises against administering naloxone to newborns whose mothers have long-term opioid use due to risk of seizures and acute withdrawal 3, 4